newsfilter
← Latest News
PR Newswire·

Provention Bio to Present at the SVB Securities Global Biopharma Conference

RED BANK, N.J., Feb. 8, 2023 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that management will